GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Pretax Margin %

Entheon Biomedical (XCNQ:ENBI) Pretax Margin % : % (As of Nov. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Entheon Biomedical's Pre-Tax Income for the three months ended in Nov. 2023 was C$-0.07 Mil. Entheon Biomedical's Revenue for the three months ended in Nov. 2023 was C$0.00 Mil. Therefore, Entheon Biomedical's pretax margin for the quarter that ended in Nov. 2023 was %.

The historical rank and industry rank for Entheon Biomedical's Pretax Margin % or its related term are showing as below:

XCNQ:ENBI' s Pretax Margin % Range Over the Past 10 Years
Min: -1084.74   Med: -602.37   Max: -120
Current: -120.4


XCNQ:ENBI's Pretax Margin % is ranked better than
53.5% of 1028 companies
in the Biotechnology industry
Industry Median: -174.24 vs XCNQ:ENBI: -120.40

Entheon Biomedical Pretax Margin % Historical Data

The historical data trend for Entheon Biomedical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Pretax Margin % Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
Pretax Margin %
Get a 7-Day Free Trial - - - -1,084.74 -120.00

Entheon Biomedical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -203.33 -80.00 -27.69 - -

Competitive Comparison of Entheon Biomedical's Pretax Margin %

For the Biotechnology subindustry, Entheon Biomedical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entheon Biomedical's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Pretax Margin % falls into.



Entheon Biomedical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Entheon Biomedical's Pretax Margin for the fiscal year that ended in Nov. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Nov. 2023 )/Revenue (A: Nov. 2023 )
=-0.3/0.25
=-120.00 %

Entheon Biomedical's Pretax Margin for the quarter that ended in Nov. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Nov. 2023 )/Revenue (Q: Nov. 2023 )
=-0.074/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entheon Biomedical  (XCNQ:ENBI) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Entheon Biomedical Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Entheon Biomedical (XCNQ:ENBI) Business Description

Traded in Other Exchanges
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines